{"gene":"PDE6G","run_date":"2026-06-10T05:19:53","timeline":{"discoveries":[{"year":1990,"finding":"Cloning of human PDE6G cDNA revealed a 261 bp coding region encoding a gamma subunit highly conserved across bovine, mouse, and human retinas; the PDEG gene was mapped to human chromosome 17q21.1; the encoded protein functions as an inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase complex (alpha-beta catalytic subunits inhibited by two identical gamma subunits).","method":"cDNA cloning, sequencing, Northern blotting, somatic cell hybrid mapping","journal":"Gene","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cloning and sequencing with chromosomal mapping, single lab but multiple orthogonal methods","pmids":["2161380"],"is_preprint":false},{"year":2001,"finding":"In vivo transgenic rescue experiments showed that the carboxyl-terminal domain of PDE6G (last 7 amino acids, Del7C) is required to maintain PDE6 catalytic activity; the Del7C transgene failed to rescue photoreceptor survival in Pdeg(tm1)/Pdeg(tm1) null mice and resulted in low PDE activity and reduced PDE6alpha and PDE6beta content, demonstrating that the C-terminus of PDE6G is necessary for maintaining PDE6alpha/beta stability and activity in vivo.","method":"Transgenic mouse rescue assay, ERG, biochemical PDE activity assay, immunoblot","journal":"Vision research","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo transgenic complementation with functional readouts (ERG, PDE activity, protein levels), multiple orthogonal methods in a single rigorous study","pmids":["11853759"],"is_preprint":false},{"year":2001,"finding":"In vivo transgenic experiments with the Y84G (Tyr84→Gly) mutation in PDE6G showed that Tyr84 is required for full regulatory control of the PDE6 catalytic core: the mutation caused a significant defect in PDE activation by transducin (biochemical assay) but only a 10-fold reduction in ERG a-wave amplitude in vivo, revealing that in vivo regulation is more dynamic than predicted by cell-free in vitro assays.","method":"Transgenic mouse rescue assay, ERG, suction electrode recording, in vitro PDE activation assay","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo transgenic complementation plus in vitro biochemical assay, multiple orthogonal functional readouts","pmids":["11171042"],"is_preprint":false},{"year":2001,"finding":"Sildenafil (a PDE inhibitor) caused a reversible, dose-dependent decrease in ERG a- and b-wave amplitudes in mice heterozygous for PDE6G knockout (PDEG:tm1/+) but not in wild-type mice, demonstrating that reduced PDE6G dosage sensitizes retinal function to PDE inhibition.","method":"ERG in heterozygous Pde6g knockout mice treated with sildenafil","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic model with pharmacological manipulation and functional readout, single lab","pmids":["11157892"],"is_preprint":false},{"year":2002,"finding":"Mouse lung was found to express rod PDE6G (Pde6g) transcripts and protein; a 14-kDa membrane protein (p14) in lung was identified as a mixture of rod (PDE6G) and cone (PDE6H) gamma subunits by immunoblot with isoform-specific antibodies; p14 immunostaining with pan-PDEgamma antibodies was substantially reduced in Pde6g-/- lung membranes, confirming PDE6G contributes to this non-retinal protein pool.","method":"RT-PCR, immunoblotting with isoform-specific antibodies, Pde6g-/- knockout comparison, subcellular fractionation (membrane fraction)","journal":"Genomics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — reciprocal antibody validation with knockout control, single lab, multiple orthogonal methods","pmids":["11944991"],"is_preprint":false},{"year":2002,"finding":"An alternative splicing variant of PDE6G was identified in human retina cDNA libraries in which a coding sequence exon is skipped, indicating the PDE6G locus produces at least two transcript isoforms in the retina.","method":"EST sequencing of human retina cDNA libraries, informatics cluster analysis","journal":"Molecular vision","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single observation from EST sequencing, no functional follow-up","pmids":["12107411"],"is_preprint":false},{"year":2003,"finding":"An allelic series of Pdeg mutations in mice (Pdeg(tm), Del7C, Y84G, W70A) produces a phenotypic spectrum from stationary night blindness to progressive retinal degeneration, establishing that different structural domains of PDE6G differentially affect the activation and deactivation phases of phototransduction in vivo.","method":"Transgenic mouse allelic series, ERG, retinal morphology","journal":"Frontiers in bioscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — defined allelic series with functional and morphological readouts, single lab","pmids":["12700134"],"is_preprint":false},{"year":2008,"finding":"In a canine PDE6A-mutant model, Western blot analysis showed that loss of PDE6A protein was accompanied by absence of PDE6B and PDE6G proteins, and no PDE6 enzymatic activity, demonstrating that PDE6A expression is essential for the normal expression and stability of the other PDE6 subunits including PDE6G.","method":"Western blot, PDE6 enzymatic activity assay in PDE6A mutant dog retinas","journal":"Investigative ophthalmology & visual science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — biochemical assays in a defined genetic model, single lab, multiple readouts","pmids":["18775863"],"is_preprint":false},{"year":2010,"finding":"A homozygous splice-site mutation (c.187+1G>T) in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans; in vitro splicing assay demonstrated the mutation leads to incorrect splicing; this established a positive (non-inhibitory) role of the PDE6G gamma subunit in maintaining phosphodiesterase activity in vivo.","method":"Homozygosity mapping, Sanger sequencing, in vitro splicing assay, ERG, funduscopy, OCT","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic mapping + molecular splicing assay + clinical functional readout (ERG), replicated across two affected sibships in one study","pmids":["20655036"],"is_preprint":false},{"year":2011,"finding":"ILE86TER transgenic mice expressing a PDE6G lacking the two C-terminal Ile86 and Ile87 residues showed decreased sensitivity and rate of activation, a decreased rate of decay of the photoresponse (consistent with reduced inhibition of PDE6alpha/beta), and higher spontaneous PDE6 activation in darkness; IBMX perfusion increased circulating current in ILE86TER rods lacking GCAPs (but not in WT), confirming higher basal PDE6 activity; this established that Ile86 and Ile87 are necessary for normal inhibitory control of PDE6 catalytic activity in vivo.","method":"Transgenic mouse rescue, suction electrode recording, ERG, IBMX pharmacological probe, Pde6g(tm1)/Pde6g(tm1) null background","journal":"Cellular signalling","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — in vivo transgenic complementation with multiple orthogonal electrophysiology and pharmacology methods, rigorous controls","pmids":["21920434"],"is_preprint":false},{"year":2011,"finding":"The N74A mutation in PDE6G, which reduces inhibition of PDE6alpha/beta in vitro, did not produce a decrease in circulating current, sensitivity, or altered response kinetics in transgenic mice expressing only N74A-PDE6G, and purified PDE6 from these mice showed no increase in basal activity; demonstrating that Asn74 is not required for normal in vivo regulation of PDE6 catalytic activity, in contrast to in vitro predictions.","method":"Transgenic mouse rescue, suction electrode ERG recording, in vitro PDE activity assay of purified enzyme","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo transgenic complementation plus biochemical assay, negative result confirmed by multiple methods, single lab","pmids":["21616145"],"is_preprint":false},{"year":2012,"finding":"Mice carrying a rod-specific Pde6g mutation showed significantly reduced vigabatrin-induced retinal toxicity compared to wild-type, demonstrating that PDE6G-mediated rod phototransduction signaling contributes to the mechanism of vigabatrin retinal toxicity.","method":"Genetic mouse model (Pde6g mutant) with vigabatrin treatment, retinal toxicity assessment","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic manipulation with defined toxicity phenotype, single lab","pmids":["22970106"],"is_preprint":false},{"year":2015,"finding":"In Pde6h-/- (cone PDEgamma subunit knockout) mice, rod PDE6G was detected in cone photoreceptors by immunohistochemistry, indicating that PDE6G can functionally substitute for PDE6H in cones when the latter is absent; this substitution was associated with preservation of visual function in mice (in contrast to human PDE6H-null patients).","method":"Immunohistochemistry, ERG, retinal morphology in Pde6h knockout mice","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse model with immunolocalization and functional ERG readout, single lab","pmids":["25739440"],"is_preprint":false},{"year":2018,"finding":"Pde6g-CreERT2-mediated conditional knockout of ARL13B in adult rod photoreceptors after outer segment maturation led to mislocalization of prenylated PDE6 (as well as rhodopsin and IFT88) and subsequent loss of photoresponse, demonstrating that ARL13B is required for proper PDE6 trafficking and maintenance in mature rod outer segments.","method":"Pde6g-CreERT2 inducible conditional knockout, immunofluorescence, ERG, retinal sectioning","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — inducible rod-specific knockout with protein localization and functional readouts, single lab; finding is about ARL13B/PDE6 interaction but uses Pde6g-CreERT2 as a tool","pmids":["30573647"],"is_preprint":false},{"year":2023,"finding":"Detailed characterization of Pde6g-/- mice showed early-onset rapid rod degeneration (majority gone by postnatal day 16), followed by retinal remodeling including inner retinal neuron changes, glial activation, retinal vascular degradation, and RPE structural abnormalities, establishing a precise timeline of RP disease progression caused by PDE6G deficiency.","method":"Immunofluorescence, immunoblot, retinal flat-mount morphometry, trypsin-digest acellular capillary assay, ERG in Pde6g-/- mice","journal":"Ophthalmology science","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — systematic characterization of null mouse model with multiple morphometric and molecular readouts, single lab","pmids":["37363133"],"is_preprint":false},{"year":2024,"finding":"ZNF124 (via its murine homolog Gm20541) was shown by CUT&Tag and RNA-seq to regulate Msx2 transcription, which in turn controls the expression of Pde6g in the retina; deletion of Gm20541 led to reduced Pde6g expression and RP-like photoreceptor degeneration, placing PDE6G downstream of a ZNF124-MSX2 transcriptional axis.","method":"Retina-specific Gm20541 knockout mouse, CUT&Tag, ChIP-exo, RNA-seq, ERG","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — knockout mouse with multi-omic transcriptional assays, single lab, Pde6g identified as a downstream target","pmids":["41708596"],"is_preprint":false}],"current_model":"PDE6G encodes the inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase (PDE6) holoenzyme; it inhibits the PDE6alpha/beta catalytic core, and its C-terminal residues (including Ile86/Ile87) are required for normal inhibitory control and basal PDE6 activity in vivo; PDE6G also stabilizes PDE6alpha and PDE6beta protein levels; loss-of-function mutations cause rapid photoreceptor degeneration and autosomal recessive retinitis pigmentosa, while PDE6G expression in non-retinal tissues (lung) and its regulation by a ZNF124-MSX2 transcriptional axis have also been experimentally established."},"narrative":{"mechanistic_narrative":"PDE6G encodes the inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase (PDE6), a holoenzyme in which two identical gamma subunits regulate the PDE6alpha/beta catalytic core that drives phototransduction [PMID:2161380]. The C-terminal residues of PDE6G are required both to maintain catalytic activity and to stabilize the alpha and beta subunits in vivo: deletion of the terminal seven residues abolishes rescue of photoreceptor survival and lowers PDE6alpha/beta content, while loss of the two C-terminal isoleucines (Ile86/Ile87) reduces inhibition of the catalytic core and elevates basal PDE6 activity in darkness [PMID:11853759, PMID:21920434]. Discrete residues contribute differentially to in vivo regulation — Tyr84 is needed for full transducin-dependent activation, whereas Asn74, which suppresses catalysis in vitro, is dispensable in vivo — establishing that intact-tissue regulation is more dynamic than cell-free assays predict [PMID:11171042, PMID:21616145]. PDE6 subunit levels are mutually interdependent, as loss of PDE6A in a canine model eliminates PDE6B and PDE6G protein and enzymatic activity [PMID:18775863]. Loss-of-function splice-site mutation in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans, and Pde6g-null mice undergo rapid early rod degeneration followed by retinal remodeling [PMID:20655036, PMID:37363133]. PDE6G expression is controlled by a ZNF124–MSX2 transcriptional axis, and the subunit is also expressed outside the retina in lung [PMID:41708596, PMID:11944991].","teleology":[{"year":1990,"claim":"Establishing the molecular identity of PDE6G defined it as the conserved inhibitory gamma subunit of rod PDE6, framing all subsequent functional work.","evidence":"cDNA cloning, sequencing, Northern blotting, and somatic cell hybrid chromosomal mapping","pmids":["2161380"],"confidence":"Medium","gaps":["Inhibitory mechanism inferred from sequence/complex composition, not directly assayed here","No structural model of gamma-catalytic core interaction"]},{"year":2001,"claim":"In vivo complementation resolved which PDE6G domains are functionally required, showing the C-terminus maintains catalytic activity and stabilizes PDE6alpha/beta while Tyr84 supports transducin-dependent activation.","evidence":"Transgenic mouse rescue on Pdeg-null background with ERG, suction electrode, in vitro PDE activity assays, and immunoblot","pmids":["11853759","11171042"],"confidence":"High","gaps":["Atomic basis of C-terminal stabilization of catalytic subunits not defined","Quantitative discrepancy between in vitro and in vivo Y84G phenotypes unexplained"]},{"year":2001,"claim":"A pharmacogenetic test showed reduced PDE6G dosage sensitizes the retina to PDE inhibition, linking gamma-subunit abundance to functional reserve.","evidence":"ERG in heterozygous Pde6g-knockout mice challenged with sildenafil","pmids":["11157892"],"confidence":"Medium","gaps":["Mechanism of dosage sensitivity at the holoenzyme level not dissected","Heterozygote phenotype only revealed under pharmacological challenge"]},{"year":2002,"claim":"Detection of PDE6G transcript and protein in lung, and an alternatively spliced retinal isoform, extended the gene's expression beyond canonical rod photoreceptors.","evidence":"RT-PCR, isoform-specific immunoblot with knockout controls, and EST analysis of retina cDNA libraries","pmids":["11944991","12107411"],"confidence":"Low","gaps":["Functional role of PDE6G in lung not established","Splice variant lacks functional follow-up","Non-retinal PDE6 holoenzyme composition unknown"]},{"year":2003,"claim":"An allelic series mapped distinct PDE6G structural domains onto separable activation and deactivation phases of phototransduction, explaining the night-blindness-to-degeneration phenotypic spectrum.","evidence":"Transgenic mouse allelic series (Pdeg-tm, Del7C, Y84G, W70A) with ERG and retinal morphology","pmids":["12700134"],"confidence":"Medium","gaps":["Per-residue contributions to deactivation kinetics not biochemically isolated","Single-lab phenotyping"]},{"year":2008,"claim":"Cross-species genetics showed the PDE6 subunits are mutually dependent for stability, with PDE6A loss eliminating PDE6B, PDE6G, and enzymatic activity.","evidence":"Western blot and PDE6 activity assay in PDE6A-mutant dog retinas","pmids":["18775863"],"confidence":"Medium","gaps":["Directionality of stabilization (which subunit chaperones which) not fully resolved","Mechanism of co-degradation unknown"]},{"year":2010,"claim":"Identifying a human splice-site mutation established PDE6G as a recessive retinitis pigmentosa gene and showed the gamma subunit has a positive, PDE6-sustaining role in vivo beyond pure inhibition.","evidence":"Homozygosity mapping, Sanger sequencing, in vitro splicing assay, and clinical ERG/OCT across two sibships","pmids":["20655036"],"confidence":"High","gaps":["Whether mutant transcript yields any residual protein not determined","Genotype-phenotype correlation across additional alleles limited"]},{"year":2011,"claim":"Residue-resolution transgenics showed Ile86/Ile87 are required for inhibitory control of the catalytic core, whereas Asn74 is dispensable in vivo despite in vitro effects, refining the inhibitory mechanism.","evidence":"Transgenic rescue on null background with suction electrode recording, ERG, IBMX probe, and purified-enzyme activity assays","pmids":["21920434","21616145"],"confidence":"High","gaps":["Structural explanation for in vitro/in vivo divergence at Asn74 unresolved","Contribution of other inhibitory contacts not exhaustively mapped"]},{"year":2012,"claim":"A rod-specific Pde6g mutant linked phototransduction signaling to drug toxicity, showing PDE6G-dependent rod signaling contributes to vigabatrin retinal damage.","evidence":"Pde6g-mutant mouse with vigabatrin treatment and retinal toxicity assessment","pmids":["22970106"],"confidence":"Medium","gaps":["Downstream molecular pathway of toxicity not defined","Generalizability beyond vigabatrin unknown"]},{"year":2015,"claim":"Demonstrating rod PDE6G can substitute in cones lacking PDE6H showed functional interchangeability of gamma subunits across photoreceptor types.","evidence":"Immunohistochemistry, ERG, and morphology in Pde6h-knockout mice","pmids":["25739440"],"confidence":"Medium","gaps":["Species difference (mouse rescue vs human PDE6H-null disease) unexplained","Stoichiometry of substitution in cone holoenzyme not quantified"]},{"year":2018,"claim":"Inducible Pde6g-CreERT2 deletion of ARL13B established that PDE6 trafficking to mature outer segments requires ARL13B, situating PDE6G within outer-segment maintenance machinery.","evidence":"Pde6g-CreERT2 inducible conditional knockout with immunofluorescence and ERG","pmids":["30573647"],"confidence":"Medium","gaps":["Direct ARL13B-PDE6 physical interaction not shown","Pde6g-CreERT2 used as a tool rather than the gene under study"]},{"year":2023,"claim":"Systematic phenotyping of Pde6g-null mice defined the temporal course of disease, from rapid early rod loss to secondary inner retinal, glial, vascular, and RPE remodeling.","evidence":"Immunofluorescence, immunoblot, flat-mount morphometry, acellular capillary assay, and ERG in Pde6g-/- mice","pmids":["37363133"],"confidence":"Medium","gaps":["Molecular triggers of secondary remodeling not identified","Therapeutic window implications not tested"]},{"year":2024,"claim":"Identifying a ZNF124-MSX2 transcriptional axis upstream of Pde6g defined how the gene's expression is controlled, linking transcriptional dysregulation to RP-like degeneration.","evidence":"Retina-specific Gm20541 knockout with CUT&Tag, ChIP-exo, RNA-seq, and ERG","pmids":["41708596"],"confidence":"Medium","gaps":["Direct MSX2 binding at the Pde6g promoter not delineated","Human relevance of the axis not confirmed"]},{"year":null,"claim":"The structural basis by which the PDE6G C-terminus simultaneously inhibits and stabilizes the catalytic core, and the function of non-retinal PDE6G, remain unresolved.","evidence":"","pmids":[],"confidence":"Low","gaps":["No atomic-resolution gamma-catalytic core structure in the corpus","Lung PDE6G function uncharacterized","Reconciliation of in vitro vs in vivo regulatory residue effects incomplete"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,9,2]}],"localization":[{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[13]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[4]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[2,9]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[2,9]}],"complexes":["rod cGMP-phosphodiesterase (PDE6) holoenzyme"],"partners":["PDE6A","PDE6B"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P18545","full_name":"Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit gamma","aliases":[],"length_aa":87,"mass_kda":9.6,"function":"Participates in processes of transmission and amplification of the visual signal. cGMP-PDEs are the effector molecules in G-protein-mediated phototransduction in vertebrate rods and cones","subcellular_location":"","url":"https://www.uniprot.org/uniprotkb/P18545/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/PDE6G","classification":"Not Classified","n_dependent_lines":27,"n_total_lines":1208,"dependency_fraction":0.022350993377483443},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/PDE6G","total_profiled":1310},"omim":[{"mim_id":"613582","title":"RETINITIS PIGMENTOSA 57; RP57","url":"https://www.omim.org/entry/613582"},{"mim_id":"268000","title":"RETINITIS PIGMENTOSA; RP","url":"https://www.omim.org/entry/268000"},{"mim_id":"180073","title":"PHOSPHODIESTERASE 6G; PDE6G","url":"https://www.omim.org/entry/180073"},{"mim_id":"180072","title":"PHOSPHODIESTERASE 6B; PDE6B","url":"https://www.omim.org/entry/180072"},{"mim_id":"180071","title":"PHOSPHODIESTERASE 6A; PDE6A","url":"https://www.omim.org/entry/180071"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Uncertain","locations":[{"location":"Vesicles","reliability":"Uncertain"}],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"retina","ntpm":1904.6}],"url":"https://www.proteinatlas.org/search/PDE6G"},"hgnc":{"alias_symbol":["RP57"],"prev_symbol":["PDEG"]},"alphafold":{"accession":"P18545","domains":[{"cath_id":"-","chopping":"60-87","consensus_level":"medium","plddt":69.0989,"start":60,"end":87}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P18545","model_url":"https://alphafold.ebi.ac.uk/files/AF-P18545-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P18545-F1-predicted_aligned_error_v6.png","plddt_mean":67.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=PDE6G","jax_strain_url":"https://www.jax.org/strain/search?query=PDE6G"},"sequence":{"accession":"P18545","fasta_url":"https://rest.uniprot.org/uniprotkb/P18545.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P18545/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P18545"}},"corpus_meta":[{"pmid":"20655036","id":"PMC_20655036","title":"Autosomal-recessive early-onset retinitis pigmentosa caused by a mutation in PDE6G, the gene encoding the gamma subunit of rod cGMP phosphodiesterase.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20655036","citation_count":69,"is_preprint":false},{"pmid":"30243637","id":"PMC_30243637","title":"Genome-wide association study of milk fatty acid composition in Italian Simmental and Italian Holstein cows using single nucleotide polymorphism arrays.","date":"2018","source":"Journal of dairy science","url":"https://pubmed.ncbi.nlm.nih.gov/30243637","citation_count":62,"is_preprint":false},{"pmid":"12107411","id":"PMC_12107411","title":"Expressed sequence tag analysis of human retina for the NEIBank Project: retbindin, an abundant, novel retinal cDNA and alternative splicing of other retina-preferred gene transcripts.","date":"2002","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/12107411","citation_count":53,"is_preprint":false},{"pmid":"18775863","id":"PMC_18775863","title":"Characterization of a canine model of autosomal recessive retinitis pigmentosa due to a PDE6A mutation.","date":"2008","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/18775863","citation_count":49,"is_preprint":false},{"pmid":"27296292","id":"PMC_27296292","title":"Evolution and expression of the phosphodiesterase 6 genes unveils vertebrate novelty to control photosensitivity.","date":"2016","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/27296292","citation_count":45,"is_preprint":false},{"pmid":"30573647","id":"PMC_30573647","title":"ARL13B, a Joubert Syndrome-Associated Protein, Is Critical for Retinogenesis and Elaboration of Mouse Photoreceptor Outer Segments.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30573647","citation_count":44,"is_preprint":false},{"pmid":"11157892","id":"PMC_11157892","title":"Sildenafil-mediated reduction in retinal function in heterozygous mice lacking the gamma-subunit of phosphodiesterase.","date":"2001","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/11157892","citation_count":40,"is_preprint":false},{"pmid":"22355572","id":"PMC_22355572","title":"Putative essential and core-essential genes in Mycoplasma genomes.","date":"2011","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/22355572","citation_count":37,"is_preprint":false},{"pmid":"31073882","id":"PMC_31073882","title":"A commonly occurring genetic variant within the NPLOC4-TSPAN10-PDE6G gene cluster is associated with the risk of strabismus.","date":"2019","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/31073882","citation_count":35,"is_preprint":false},{"pmid":"2161380","id":"PMC_2161380","title":"Isolation and characterization of cDNA encoding the gamma-subunit of cGMP phosphodiesterase in human retina.","date":"1990","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/2161380","citation_count":35,"is_preprint":false},{"pmid":"30229962","id":"PMC_30229962","title":"Gene set enrichment analysis of SNP data in dairy and beef cattle with bovine respiratory disease.","date":"2018","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/30229962","citation_count":30,"is_preprint":false},{"pmid":"25739440","id":"PMC_25739440","title":"Targeted ablation of the Pde6h gene in mice reveals cross-species differences in cone and rod phototransduction protein isoform inventory.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25739440","citation_count":27,"is_preprint":false},{"pmid":"24683528","id":"PMC_24683528","title":"Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells.","date":"2013","source":"SpringerPlus","url":"https://pubmed.ncbi.nlm.nih.gov/24683528","citation_count":25,"is_preprint":false},{"pmid":"2538340","id":"PMC_2538340","title":"The gene for the gamma-subunit of retinal cGMP-phosphodiesterase is on mouse chromosome 11.","date":"1989","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/2538340","citation_count":23,"is_preprint":false},{"pmid":"8125719","id":"PMC_8125719","title":"Evaluation of the gene encoding the gamma subunit of rod phosphodiesterase in retinitis pigmentosa.","date":"1994","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/8125719","citation_count":23,"is_preprint":false},{"pmid":"20979602","id":"PMC_20979602","title":"Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis.","date":"2010","source":"Respiratory research","url":"https://pubmed.ncbi.nlm.nih.gov/20979602","citation_count":21,"is_preprint":false},{"pmid":"22970106","id":"PMC_22970106","title":"Vigabatrin-induced retinal toxicity is partially mediated by signaling in rod and cone photoreceptors.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22970106","citation_count":19,"is_preprint":false},{"pmid":"9385361","id":"PMC_9385361","title":"Retinitis pigmentosa locus on 17q (RP17): fine localization to 17q22 and exclusion of the PDEG and TIMP2 genes.","date":"1997","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9385361","citation_count":17,"is_preprint":false},{"pmid":"11853759","id":"PMC_11853759","title":"The positive role of the carboxyl terminus of the gamma subunit of retinal cGMP-phosphodiesterase in maintaining phosphodiesterase activity in vivo.","date":"2002","source":"Vision research","url":"https://pubmed.ncbi.nlm.nih.gov/11853759","citation_count":17,"is_preprint":false},{"pmid":"15819430","id":"PMC_15819430","title":"A cohabitation challenge to compare the efficacies of vaccines for bacterial kidney disease (BKD) in chinook salmon Oncorhynchus tshawytscha.","date":"2005","source":"Diseases of aquatic organisms","url":"https://pubmed.ncbi.nlm.nih.gov/15819430","citation_count":17,"is_preprint":false},{"pmid":"11171042","id":"PMC_11171042","title":"In vivo studies of the gamma subunit of retinal cGMP-phophodiesterase with a substitution of tyrosine-84.","date":"2001","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/11171042","citation_count":14,"is_preprint":false},{"pmid":"34674599","id":"PMC_34674599","title":"lncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p.","date":"2021","source":"Archives of physiology and biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/34674599","citation_count":13,"is_preprint":false},{"pmid":"34670485","id":"PMC_34670485","title":"Differential expression analysis using a model-based gene clustering algorithm for RNA-seq data.","date":"2021","source":"BMC bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/34670485","citation_count":13,"is_preprint":false},{"pmid":"11944991","id":"PMC_11944991","title":"The identification of the inhibitory gamma-subunits of the type 6 retinal cyclic guanosine monophosphate phosphodiesterase in non-retinal tissues: differential processing of mRNA transcripts.","date":"2002","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11944991","citation_count":13,"is_preprint":false},{"pmid":"12700134","id":"PMC_12700134","title":"Stationary night blindness or progressive retinal degeneration in mice carrying different alleles of PDE gamma.","date":"2003","source":"Frontiers in bioscience : a journal and virtual library","url":"https://pubmed.ncbi.nlm.nih.gov/12700134","citation_count":11,"is_preprint":false},{"pmid":"10504278","id":"PMC_10504278","title":"Evaluation of cGMP-phosphodiesterase (PDE) subunits for causal association with rod-cone dysplasia 2 (rcd2), a canine model of abnormal retinal cGMP metabolism.","date":"1999","source":"Experimental eye research","url":"https://pubmed.ncbi.nlm.nih.gov/10504278","citation_count":10,"is_preprint":false},{"pmid":"30007273","id":"PMC_30007273","title":"Lateralized expression of left-right axis formation genes is shared by adult brains of lefty and righty scale-eating cichlids.","date":"2018","source":"Comparative biochemistry and physiology. Part D, Genomics & proteomics","url":"https://pubmed.ncbi.nlm.nih.gov/30007273","citation_count":10,"is_preprint":false},{"pmid":"1330890","id":"PMC_1330890","title":"Syntenic assignments of visual transduction genes in cattle.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1330890","citation_count":10,"is_preprint":false},{"pmid":"26207987","id":"PMC_26207987","title":"The Biosynthesis of UDP-D-QuiNAc in Bacillus cereus ATCC 14579.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26207987","citation_count":9,"is_preprint":false},{"pmid":"27859739","id":"PMC_27859739","title":"Transcriptomic responses in the oral cavity of F344 rats and B6C3F1 mice following exposure to Cr(VI): Implications for risk assessment.","date":"2016","source":"Environmental and molecular mutagenesis","url":"https://pubmed.ncbi.nlm.nih.gov/27859739","citation_count":9,"is_preprint":false},{"pmid":"38698486","id":"PMC_38698486","title":"Deciphering Müller cell heterogeneity signatures in diabetic retinopathy across species: an integrative single-cell analysis.","date":"2024","source":"European journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/38698486","citation_count":9,"is_preprint":false},{"pmid":"21920434","id":"PMC_21920434","title":"Effect of the ILE86TER mutation in the γ subunit of cGMP phosphodiesterase (PDE6) on rod photoreceptor signaling.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21920434","citation_count":8,"is_preprint":false},{"pmid":"37363133","id":"PMC_37363133","title":"A New Preclinical Model of Retinitis Pigmentosa Due to Pde6g Deficiency.","date":"2023","source":"Ophthalmology science","url":"https://pubmed.ncbi.nlm.nih.gov/37363133","citation_count":7,"is_preprint":false},{"pmid":"35967305","id":"PMC_35967305","title":"A Cross-Tissue Transcriptome-Wide Association Study Identifies Novel Susceptibility Genes for Juvenile Idiopathic Arthritis in Asia and Europe.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35967305","citation_count":7,"is_preprint":false},{"pmid":"17356515","id":"PMC_17356515","title":"Association of the Asn306Ser variant of the SP4 transcription factor and an intronic variant in the beta-subunit of transducin with digenic disease.","date":"2007","source":"Molecular vision","url":"https://pubmed.ncbi.nlm.nih.gov/17356515","citation_count":7,"is_preprint":false},{"pmid":"38290548","id":"PMC_38290548","title":"Deficiency of the ribosomal protein uS10 (RPS20) reorganizes human cells translatome according to the abundance, CDS length and GC content of mRNAs.","date":"2024","source":"Open biology","url":"https://pubmed.ncbi.nlm.nih.gov/38290548","citation_count":6,"is_preprint":false},{"pmid":"12927076","id":"PMC_12927076","title":"Analysis of PDE6D and PDE6G genes for generalised progressive retinal atrophy (gPRA) mutations in dogs.","date":"2003","source":"Genetics, selection, evolution : GSE","url":"https://pubmed.ncbi.nlm.nih.gov/12927076","citation_count":5,"is_preprint":false},{"pmid":"21616145","id":"PMC_21616145","title":"Function of the asparagine 74 residue of the inhibitory γ-subunit of retinal rod cGMP-phophodiesterase (PDE) in vivo.","date":"2011","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/21616145","citation_count":5,"is_preprint":false},{"pmid":"12464018","id":"PMC_12464018","title":"Autosomal dominant retinal dystrophy (Rdy) in Abyssinian cats: exclusion of PDE6G and ROM1 and likely exclusion of Rhodopsin as candidate genes.","date":"2002","source":"Animal genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12464018","citation_count":4,"is_preprint":false},{"pmid":"36660900","id":"PMC_36660900","title":"Transcriptome-wide association study identifies new susceptibility genes for degenerative cervical spondylosis.","date":"2023","source":"Bone & joint research","url":"https://pubmed.ncbi.nlm.nih.gov/36660900","citation_count":4,"is_preprint":false},{"pmid":"41407926","id":"PMC_41407926","title":"Orthogonal RNA-regulated destabilization domains for three-color RNA imaging with minimal RNA perturbation.","date":"2025","source":"Nature methods","url":"https://pubmed.ncbi.nlm.nih.gov/41407926","citation_count":4,"is_preprint":false},{"pmid":"27776529","id":"PMC_27776529","title":"Biosynthesis of three N-acetylaminosugar-conjugated flavonoids using engineered Escherichia coli.","date":"2016","source":"Microbial cell factories","url":"https://pubmed.ncbi.nlm.nih.gov/27776529","citation_count":4,"is_preprint":false},{"pmid":"38493223","id":"PMC_38493223","title":"Paternal-effect-genes revealed through sperm cryopreservation in Perca fluviatilis.","date":"2024","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/38493223","citation_count":4,"is_preprint":false},{"pmid":"35147831","id":"PMC_35147831","title":"Integrative RNA-seq and ATAC-seq analyses of phosphodiesterase 6 mutation-induced retinitis pigmentosa.","date":"2022","source":"International ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/35147831","citation_count":3,"is_preprint":false},{"pmid":"37318461","id":"PMC_37318461","title":"Identification of hub genes correlated with diabetic retinopathy via bioinformatics methods.","date":"2023","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/37318461","citation_count":2,"is_preprint":false},{"pmid":"39160471","id":"PMC_39160471","title":"Analysis of PDE6G mutations in a patient with retinitis pigmentosa.","date":"2024","source":"BMC ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/39160471","citation_count":1,"is_preprint":false},{"pmid":"37667381","id":"PMC_37667381","title":"Transcriptome-wide association study identifies new susceptibility genes and pathways for spondyloarthritis.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/37667381","citation_count":1,"is_preprint":false},{"pmid":"23868983","id":"PMC_23868983","title":"Selection of Phototransduction Genes in Homo sapiens.","date":"2013","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/23868983","citation_count":1,"is_preprint":false},{"pmid":"40736827","id":"PMC_40736827","title":"Retinitis Pigmentosa (Non-syndromic).","date":"2025","source":"Advances in experimental medicine and biology","url":"https://pubmed.ncbi.nlm.nih.gov/40736827","citation_count":0,"is_preprint":false},{"pmid":"39055259","id":"PMC_39055259","title":"Cross-species single-cell landscapes identify the pathogenic gene characteristics of inherited retinal diseases.","date":"2024","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39055259","citation_count":0,"is_preprint":false},{"pmid":"41721232","id":"PMC_41721232","title":"Post-thaw storage of sperm as a tool towards revealing paternal-effect-associated genes in Eurasian perch, Perca fluviatilis.","date":"2026","source":"BMC genomics","url":"https://pubmed.ncbi.nlm.nih.gov/41721232","citation_count":0,"is_preprint":false},{"pmid":"41708596","id":"PMC_41708596","title":"Unveiling ZNF124 as a novel determinant in neurodegeneration: orchestration of photoreceptor homeostasis through MSX2 transcriptional regulation.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41708596","citation_count":0,"is_preprint":false},{"pmid":"39544142","id":"PMC_39544142","title":"Analysis of candidate variants in a Chinese family with monozygotic twins with keratoconus: a case report.","date":"2024","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39544142","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":28551,"output_tokens":3913,"usd":0.072174,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":11771,"output_tokens":3977,"usd":0.07914,"stage2_stop_reason":"end_turn"},"total_usd":0.151314,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1990,\n      \"finding\": \"Cloning of human PDE6G cDNA revealed a 261 bp coding region encoding a gamma subunit highly conserved across bovine, mouse, and human retinas; the PDEG gene was mapped to human chromosome 17q21.1; the encoded protein functions as an inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase complex (alpha-beta catalytic subunits inhibited by two identical gamma subunits).\",\n      \"method\": \"cDNA cloning, sequencing, Northern blotting, somatic cell hybrid mapping\",\n      \"journal\": \"Gene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cloning and sequencing with chromosomal mapping, single lab but multiple orthogonal methods\",\n      \"pmids\": [\"2161380\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In vivo transgenic rescue experiments showed that the carboxyl-terminal domain of PDE6G (last 7 amino acids, Del7C) is required to maintain PDE6 catalytic activity; the Del7C transgene failed to rescue photoreceptor survival in Pdeg(tm1)/Pdeg(tm1) null mice and resulted in low PDE activity and reduced PDE6alpha and PDE6beta content, demonstrating that the C-terminus of PDE6G is necessary for maintaining PDE6alpha/beta stability and activity in vivo.\",\n      \"method\": \"Transgenic mouse rescue assay, ERG, biochemical PDE activity assay, immunoblot\",\n      \"journal\": \"Vision research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo transgenic complementation with functional readouts (ERG, PDE activity, protein levels), multiple orthogonal methods in a single rigorous study\",\n      \"pmids\": [\"11853759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"In vivo transgenic experiments with the Y84G (Tyr84→Gly) mutation in PDE6G showed that Tyr84 is required for full regulatory control of the PDE6 catalytic core: the mutation caused a significant defect in PDE activation by transducin (biochemical assay) but only a 10-fold reduction in ERG a-wave amplitude in vivo, revealing that in vivo regulation is more dynamic than predicted by cell-free in vitro assays.\",\n      \"method\": \"Transgenic mouse rescue assay, ERG, suction electrode recording, in vitro PDE activation assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo transgenic complementation plus in vitro biochemical assay, multiple orthogonal functional readouts\",\n      \"pmids\": [\"11171042\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Sildenafil (a PDE inhibitor) caused a reversible, dose-dependent decrease in ERG a- and b-wave amplitudes in mice heterozygous for PDE6G knockout (PDEG:tm1/+) but not in wild-type mice, demonstrating that reduced PDE6G dosage sensitizes retinal function to PDE inhibition.\",\n      \"method\": \"ERG in heterozygous Pde6g knockout mice treated with sildenafil\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic model with pharmacological manipulation and functional readout, single lab\",\n      \"pmids\": [\"11157892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Mouse lung was found to express rod PDE6G (Pde6g) transcripts and protein; a 14-kDa membrane protein (p14) in lung was identified as a mixture of rod (PDE6G) and cone (PDE6H) gamma subunits by immunoblot with isoform-specific antibodies; p14 immunostaining with pan-PDEgamma antibodies was substantially reduced in Pde6g-/- lung membranes, confirming PDE6G contributes to this non-retinal protein pool.\",\n      \"method\": \"RT-PCR, immunoblotting with isoform-specific antibodies, Pde6g-/- knockout comparison, subcellular fractionation (membrane fraction)\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — reciprocal antibody validation with knockout control, single lab, multiple orthogonal methods\",\n      \"pmids\": [\"11944991\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"An alternative splicing variant of PDE6G was identified in human retina cDNA libraries in which a coding sequence exon is skipped, indicating the PDE6G locus produces at least two transcript isoforms in the retina.\",\n      \"method\": \"EST sequencing of human retina cDNA libraries, informatics cluster analysis\",\n      \"journal\": \"Molecular vision\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single observation from EST sequencing, no functional follow-up\",\n      \"pmids\": [\"12107411\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"An allelic series of Pdeg mutations in mice (Pdeg(tm), Del7C, Y84G, W70A) produces a phenotypic spectrum from stationary night blindness to progressive retinal degeneration, establishing that different structural domains of PDE6G differentially affect the activation and deactivation phases of phototransduction in vivo.\",\n      \"method\": \"Transgenic mouse allelic series, ERG, retinal morphology\",\n      \"journal\": \"Frontiers in bioscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — defined allelic series with functional and morphological readouts, single lab\",\n      \"pmids\": [\"12700134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"In a canine PDE6A-mutant model, Western blot analysis showed that loss of PDE6A protein was accompanied by absence of PDE6B and PDE6G proteins, and no PDE6 enzymatic activity, demonstrating that PDE6A expression is essential for the normal expression and stability of the other PDE6 subunits including PDE6G.\",\n      \"method\": \"Western blot, PDE6 enzymatic activity assay in PDE6A mutant dog retinas\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — biochemical assays in a defined genetic model, single lab, multiple readouts\",\n      \"pmids\": [\"18775863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A homozygous splice-site mutation (c.187+1G>T) in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans; in vitro splicing assay demonstrated the mutation leads to incorrect splicing; this established a positive (non-inhibitory) role of the PDE6G gamma subunit in maintaining phosphodiesterase activity in vivo.\",\n      \"method\": \"Homozygosity mapping, Sanger sequencing, in vitro splicing assay, ERG, funduscopy, OCT\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic mapping + molecular splicing assay + clinical functional readout (ERG), replicated across two affected sibships in one study\",\n      \"pmids\": [\"20655036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"ILE86TER transgenic mice expressing a PDE6G lacking the two C-terminal Ile86 and Ile87 residues showed decreased sensitivity and rate of activation, a decreased rate of decay of the photoresponse (consistent with reduced inhibition of PDE6alpha/beta), and higher spontaneous PDE6 activation in darkness; IBMX perfusion increased circulating current in ILE86TER rods lacking GCAPs (but not in WT), confirming higher basal PDE6 activity; this established that Ile86 and Ile87 are necessary for normal inhibitory control of PDE6 catalytic activity in vivo.\",\n      \"method\": \"Transgenic mouse rescue, suction electrode recording, ERG, IBMX pharmacological probe, Pde6g(tm1)/Pde6g(tm1) null background\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — in vivo transgenic complementation with multiple orthogonal electrophysiology and pharmacology methods, rigorous controls\",\n      \"pmids\": [\"21920434\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"The N74A mutation in PDE6G, which reduces inhibition of PDE6alpha/beta in vitro, did not produce a decrease in circulating current, sensitivity, or altered response kinetics in transgenic mice expressing only N74A-PDE6G, and purified PDE6 from these mice showed no increase in basal activity; demonstrating that Asn74 is not required for normal in vivo regulation of PDE6 catalytic activity, in contrast to in vitro predictions.\",\n      \"method\": \"Transgenic mouse rescue, suction electrode ERG recording, in vitro PDE activity assay of purified enzyme\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo transgenic complementation plus biochemical assay, negative result confirmed by multiple methods, single lab\",\n      \"pmids\": [\"21616145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mice carrying a rod-specific Pde6g mutation showed significantly reduced vigabatrin-induced retinal toxicity compared to wild-type, demonstrating that PDE6G-mediated rod phototransduction signaling contributes to the mechanism of vigabatrin retinal toxicity.\",\n      \"method\": \"Genetic mouse model (Pde6g mutant) with vigabatrin treatment, retinal toxicity assessment\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic manipulation with defined toxicity phenotype, single lab\",\n      \"pmids\": [\"22970106\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Pde6h-/- (cone PDEgamma subunit knockout) mice, rod PDE6G was detected in cone photoreceptors by immunohistochemistry, indicating that PDE6G can functionally substitute for PDE6H in cones when the latter is absent; this substitution was associated with preservation of visual function in mice (in contrast to human PDE6H-null patients).\",\n      \"method\": \"Immunohistochemistry, ERG, retinal morphology in Pde6h knockout mice\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse model with immunolocalization and functional ERG readout, single lab\",\n      \"pmids\": [\"25739440\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Pde6g-CreERT2-mediated conditional knockout of ARL13B in adult rod photoreceptors after outer segment maturation led to mislocalization of prenylated PDE6 (as well as rhodopsin and IFT88) and subsequent loss of photoresponse, demonstrating that ARL13B is required for proper PDE6 trafficking and maintenance in mature rod outer segments.\",\n      \"method\": \"Pde6g-CreERT2 inducible conditional knockout, immunofluorescence, ERG, retinal sectioning\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — inducible rod-specific knockout with protein localization and functional readouts, single lab; finding is about ARL13B/PDE6 interaction but uses Pde6g-CreERT2 as a tool\",\n      \"pmids\": [\"30573647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Detailed characterization of Pde6g-/- mice showed early-onset rapid rod degeneration (majority gone by postnatal day 16), followed by retinal remodeling including inner retinal neuron changes, glial activation, retinal vascular degradation, and RPE structural abnormalities, establishing a precise timeline of RP disease progression caused by PDE6G deficiency.\",\n      \"method\": \"Immunofluorescence, immunoblot, retinal flat-mount morphometry, trypsin-digest acellular capillary assay, ERG in Pde6g-/- mice\",\n      \"journal\": \"Ophthalmology science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — systematic characterization of null mouse model with multiple morphometric and molecular readouts, single lab\",\n      \"pmids\": [\"37363133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"ZNF124 (via its murine homolog Gm20541) was shown by CUT&Tag and RNA-seq to regulate Msx2 transcription, which in turn controls the expression of Pde6g in the retina; deletion of Gm20541 led to reduced Pde6g expression and RP-like photoreceptor degeneration, placing PDE6G downstream of a ZNF124-MSX2 transcriptional axis.\",\n      \"method\": \"Retina-specific Gm20541 knockout mouse, CUT&Tag, ChIP-exo, RNA-seq, ERG\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — knockout mouse with multi-omic transcriptional assays, single lab, Pde6g identified as a downstream target\",\n      \"pmids\": [\"41708596\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"PDE6G encodes the inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase (PDE6) holoenzyme; it inhibits the PDE6alpha/beta catalytic core, and its C-terminal residues (including Ile86/Ile87) are required for normal inhibitory control and basal PDE6 activity in vivo; PDE6G also stabilizes PDE6alpha and PDE6beta protein levels; loss-of-function mutations cause rapid photoreceptor degeneration and autosomal recessive retinitis pigmentosa, while PDE6G expression in non-retinal tissues (lung) and its regulation by a ZNF124-MSX2 transcriptional axis have also been experimentally established.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"PDE6G encodes the inhibitory gamma subunit of the rod photoreceptor cGMP-phosphodiesterase (PDE6), a holoenzyme in which two identical gamma subunits regulate the PDE6alpha/beta catalytic core that drives phototransduction [#0]. The C-terminal residues of PDE6G are required both to maintain catalytic activity and to stabilize the alpha and beta subunits in vivo: deletion of the terminal seven residues abolishes rescue of photoreceptor survival and lowers PDE6alpha/beta content, while loss of the two C-terminal isoleucines (Ile86/Ile87) reduces inhibition of the catalytic core and elevates basal PDE6 activity in darkness [#1, #9]. Discrete residues contribute differentially to in vivo regulation — Tyr84 is needed for full transducin-dependent activation, whereas Asn74, which suppresses catalysis in vitro, is dispensable in vivo — establishing that intact-tissue regulation is more dynamic than cell-free assays predict [#2, #10]. PDE6 subunit levels are mutually interdependent, as loss of PDE6A in a canine model eliminates PDE6B and PDE6G protein and enzymatic activity [#7]. Loss-of-function splice-site mutation in PDE6G causes autosomal recessive early-onset retinitis pigmentosa in humans, and Pde6g-null mice undergo rapid early rod degeneration followed by retinal remodeling [#8, #14]. PDE6G expression is controlled by a ZNF124–MSX2 transcriptional axis, and the subunit is also expressed outside the retina in lung [#15, #4].\"\n,\n  \"teleology\": [\n    {\n      \"year\": 1990,\n      \"claim\": \"Establishing the molecular identity of PDE6G defined it as the conserved inhibitory gamma subunit of rod PDE6, framing all subsequent functional work.\",\n      \"evidence\": \"cDNA cloning, sequencing, Northern blotting, and somatic cell hybrid chromosomal mapping\",\n      \"pmids\": [\"2161380\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Inhibitory mechanism inferred from sequence/complex composition, not directly assayed here\", \"No structural model of gamma-catalytic core interaction\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"In vivo complementation resolved which PDE6G domains are functionally required, showing the C-terminus maintains catalytic activity and stabilizes PDE6alpha/beta while Tyr84 supports transducin-dependent activation.\",\n      \"evidence\": \"Transgenic mouse rescue on Pdeg-null background with ERG, suction electrode, in vitro PDE activity assays, and immunoblot\",\n      \"pmids\": [\"11853759\", \"11171042\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic basis of C-terminal stabilization of catalytic subunits not defined\", \"Quantitative discrepancy between in vitro and in vivo Y84G phenotypes unexplained\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"A pharmacogenetic test showed reduced PDE6G dosage sensitizes the retina to PDE inhibition, linking gamma-subunit abundance to functional reserve.\",\n      \"evidence\": \"ERG in heterozygous Pde6g-knockout mice challenged with sildenafil\",\n      \"pmids\": [\"11157892\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of dosage sensitivity at the holoenzyme level not dissected\", \"Heterozygote phenotype only revealed under pharmacological challenge\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Detection of PDE6G transcript and protein in lung, and an alternatively spliced retinal isoform, extended the gene's expression beyond canonical rod photoreceptors.\",\n      \"evidence\": \"RT-PCR, isoform-specific immunoblot with knockout controls, and EST analysis of retina cDNA libraries\",\n      \"pmids\": [\"11944991\", \"12107411\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Functional role of PDE6G in lung not established\", \"Splice variant lacks functional follow-up\", \"Non-retinal PDE6 holoenzyme composition unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"An allelic series mapped distinct PDE6G structural domains onto separable activation and deactivation phases of phototransduction, explaining the night-blindness-to-degeneration phenotypic spectrum.\",\n      \"evidence\": \"Transgenic mouse allelic series (Pdeg-tm, Del7C, Y84G, W70A) with ERG and retinal morphology\",\n      \"pmids\": [\"12700134\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Per-residue contributions to deactivation kinetics not biochemically isolated\", \"Single-lab phenotyping\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Cross-species genetics showed the PDE6 subunits are mutually dependent for stability, with PDE6A loss eliminating PDE6B, PDE6G, and enzymatic activity.\",\n      \"evidence\": \"Western blot and PDE6 activity assay in PDE6A-mutant dog retinas\",\n      \"pmids\": [\"18775863\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Directionality of stabilization (which subunit chaperones which) not fully resolved\", \"Mechanism of co-degradation unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying a human splice-site mutation established PDE6G as a recessive retinitis pigmentosa gene and showed the gamma subunit has a positive, PDE6-sustaining role in vivo beyond pure inhibition.\",\n      \"evidence\": \"Homozygosity mapping, Sanger sequencing, in vitro splicing assay, and clinical ERG/OCT across two sibships\",\n      \"pmids\": [\"20655036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether mutant transcript yields any residual protein not determined\", \"Genotype-phenotype correlation across additional alleles limited\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Residue-resolution transgenics showed Ile86/Ile87 are required for inhibitory control of the catalytic core, whereas Asn74 is dispensable in vivo despite in vitro effects, refining the inhibitory mechanism.\",\n      \"evidence\": \"Transgenic rescue on null background with suction electrode recording, ERG, IBMX probe, and purified-enzyme activity assays\",\n      \"pmids\": [\"21920434\", \"21616145\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural explanation for in vitro/in vivo divergence at Asn74 unresolved\", \"Contribution of other inhibitory contacts not exhaustively mapped\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"A rod-specific Pde6g mutant linked phototransduction signaling to drug toxicity, showing PDE6G-dependent rod signaling contributes to vigabatrin retinal damage.\",\n      \"evidence\": \"Pde6g-mutant mouse with vigabatrin treatment and retinal toxicity assessment\",\n      \"pmids\": [\"22970106\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream molecular pathway of toxicity not defined\", \"Generalizability beyond vigabatrin unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating rod PDE6G can substitute in cones lacking PDE6H showed functional interchangeability of gamma subunits across photoreceptor types.\",\n      \"evidence\": \"Immunohistochemistry, ERG, and morphology in Pde6h-knockout mice\",\n      \"pmids\": [\"25739440\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Species difference (mouse rescue vs human PDE6H-null disease) unexplained\", \"Stoichiometry of substitution in cone holoenzyme not quantified\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Inducible Pde6g-CreERT2 deletion of ARL13B established that PDE6 trafficking to mature outer segments requires ARL13B, situating PDE6G within outer-segment maintenance machinery.\",\n      \"evidence\": \"Pde6g-CreERT2 inducible conditional knockout with immunofluorescence and ERG\",\n      \"pmids\": [\"30573647\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct ARL13B-PDE6 physical interaction not shown\", \"Pde6g-CreERT2 used as a tool rather than the gene under study\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Systematic phenotyping of Pde6g-null mice defined the temporal course of disease, from rapid early rod loss to secondary inner retinal, glial, vascular, and RPE remodeling.\",\n      \"evidence\": \"Immunofluorescence, immunoblot, flat-mount morphometry, acellular capillary assay, and ERG in Pde6g-/- mice\",\n      \"pmids\": [\"37363133\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular triggers of secondary remodeling not identified\", \"Therapeutic window implications not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Identifying a ZNF124-MSX2 transcriptional axis upstream of Pde6g defined how the gene's expression is controlled, linking transcriptional dysregulation to RP-like degeneration.\",\n      \"evidence\": \"Retina-specific Gm20541 knockout with CUT&Tag, ChIP-exo, RNA-seq, and ERG\",\n      \"pmids\": [\"41708596\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MSX2 binding at the Pde6g promoter not delineated\", \"Human relevance of the axis not confirmed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The structural basis by which the PDE6G C-terminus simultaneously inhibits and stabilizes the catalytic core, and the function of non-retinal PDE6G, remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No atomic-resolution gamma-catalytic core structure in the corpus\", \"Lung PDE6G function uncharacterized\", \"Reconciliation of in vitro vs in vivo regulatory residue effects incomplete\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 9, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [13]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [2, 9]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 9]}\n    ],\n    \"complexes\": [\"rod cGMP-phosphodiesterase (PDE6) holoenzyme\"],\n    \"partners\": [\"PDE6A\", \"PDE6B\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}